MOM-M281-004 extension study (M281)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MOM-M281-004 extension study (M281), covering 2022-02-16 to 2022-02-16. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis [Phase 2]